Asia Pacific Nucleic Acid Isolation and Purification Market Size, Growth, Share & Trends Analysis
Asia Pacific Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), & End User (CROs) - Forecast to 2030
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Asia Pacific nucleic acid isolation and purification market, valued at US$1.49 billion in 2024, stood at US$1.61 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.65 billion by the end of the period. The Asia Pacific market for nucleic acid isolation and purification is expanding due to the increasing number of molecular tests and the scale-up of PCR and NGS across the region. To meet the demand for infectious disease screening, respiratory panels, and outbreak surveillance, hospitals and large reference labs are installing automated, high-throughput extraction systems. Demand from public health programs, newborn screening, and the growing prevalence of genetic testing is consistent in countries such as China, India, Japan, South Korea, and Australia.
KEY TAKEAWAYS
-
By CountryChina accounted for a 35.2% share of the nucleic acid isolation and purification market in 2024.
-
By ProductBy product, the kits segment is expected to register the highest growth rate of 11.1% in the Asia Pacific nucleic acid isolation and purification market during the forecast period.
-
By TypeBy type, the plasmid DNA isolation and purification segment dominated the market in 2024 with a share of 21.9%.
-
By methodBy method, the magnetic bead-based isolation and purification segment dominated the market in 2024.
-
By ApplicationBy application, the personalized medicine segment is projected to grow at the fastest rate from 2025 to 2030.
-
Competitive LandscapeCompanies such as Thermo Fisher Scientific, Merck KGaA, and QIAGEN were identified as key players in the Europe nucleic acid isolation and purification market, due to their strong market share and extensive product portfolio.
The Asia Pacific nucleic acid isolation and purification is a significantly growing regional market. The rise in PCR and NGS testing in hospitals, diagnostic laboratories, and research centers has contributed to this growth. Labs are increasingly focusing on the purity and homogeneity of DNA/RNA to be able to support infectious disease screening, oncology panels, genetic testing, and microbiome studies. The need for liquid biopsy and cfDNA workflows is also growing, mostly in developed countries, where assay sensitivity depends greatly on the quality of the extraction.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The impact on stakeholders in the Asia Pacific nucleic acid isolation and purification market is driven by the region’s rapid shift toward molecular decision-making in healthcare and life sciences. PCR, qPCR, and NGS are becoming routine across infectious disease testing, oncology profiling, and genetic screening. This makes high-quality, inhibitor-free DNA/RNA extraction a non-negotiable first step.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Growth in PCR/qPCR testing across routine diagnostics
-
Faster clinical adoption of NGS in oncology and precision medicine
Level
-
High cost of automation platforms and recurring consumables
Level
-
Expansion of liquid biopsy and plasma-based oncology testing
Level
-
Skills and infrastructure gaps for high-throughput molecular workflows
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growth in PCR/qPCR testing across routine diagnostics
Hospitals and diagnostic chains in the Asia Pacific region are running high volumes of molecular tests. That keeps nucleic acid extraction as a routine, repeat purchase category. Labs are focusing on cleaner DNA/RNA because inhibitors are revealed fast in PCR runs. Public health labs also keep a baseline load for respiratory and outbreak monitoring. This is creating steady demand for reliable kits and standardized workflows. It is also driving labs to prefer formats that reduce steps and errors.
Restraint: High cost of automation platforms and recurring consumables
Automated extraction improves throughput, but the entry cost is significant. Recurring spend on plastics, reagents and service contracts adds cost pressure. Smaller labs often stay manual even if demand is rising. Cost is also becoming a barrier when workflows need multiple kits per sample type. Several studies note that automated options can be more expensive than manual routes. This slows adoption in price-sensitive segments of the Asia Pacific region.
Opportunity: Expansion of liquid biopsy and plasma-based oncology testing
Liquid biopsy use is growing for selected clinical decisions in oncology. These workflows are sensitive to extraction quality and cfDNA yield. As more systems adopt NGS-based profiling, plasma workflows are also growing. This, in turn, is increasing demand for dedicated cfDNA kits and cleanroom-like handling. Labs also require stringent controls to avoid low-input losses. Suppliers can win by offering end-to-end validated workflows for plasma.
Challenge: Skills and infrastructure gaps for high-throughput molecular workflows
Automation reduces hands-on time, but it requires trained operators and maintenance. Many labs are still facing staffing gaps in molecular quality systems. Contamination control is a constant risk as volumes increase. Sequencing expansion also brings bioinformatics and data workflow needs. These gaps can slow scaling outside major reference centers.
ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
AIIMS Raipur planned to scale its molecular testing capacity for high-throughput infectious disease workflows. It moved toward automated nucleic acid extraction to reduce manual handling and improve repeatability. | Faster sample-to-result turnaround | Higher daily throughput with less hands-on time | More consistent DNA/RNA yield and purity across operators | Lower re-run risk due to cleaner extraction |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The Asia Pacific nucleic acid isolation and purification market ecosystem comprises the complete sample-to-result chain. It includes suppliers of extraction kits and core reagents such as lysis buffers, silica columns, magnetic beads, and wash/elution chemistries. It also includes providers of manual and semi-automated kits used widely in routine labs, along with fully automated extraction platforms used in high-throughput diagnostic and reference labs. Cold-chain and logistics partners also play an important role in the Asia Pacific region because sample movement often crosses cities, islands, and remote regions.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Asia Pacific Nucleic Acid Isolation and Purification Market, by Product
In 2024, kits were the dominant product segment in the Asia Pacific nucleic acid isolation and purification market. This is mainly due to the consumables-heavy nature of extraction workflows, where fresh DNA/RNA extraction reagents are required for every run. Clinical labs and large diagnostic chains across the Asia Pacific region prefer kits because they are validated, easy to standardize, and simpler to use across multiple operators and sites.
Asia Pacific Nucleic Acid Isolation and Purification Market, by Type
As of 2024, plasmid DNA isolation and purification is a dominant type segment in the Asia Pacific market. Biopharma and biotech labs across China, India, Japan, South Korea, Singapore, and Australia run plasmid preparation on a routine basis for cloning, recombinant protein expression, and assay development. This is creating repeat, high-frequency demand for these prep kits in research labs and CROs.
Asia Pacific Nucleic Acid Isolation and Purification Market, by Method
In 2024, magnetic bead-based isolation and purification dominated the method segment in the Asia Pacific as it fits high-volume, routine molecular testing. Large diagnostic chains and reference labs prefer bead workflows since they scale fast, run well on automation, and support consistent turnaround for PCR and NGS. It also reduces manual steps, which helps when labs face staffing constraints and require repeatable outcomes across runs.
Asia Pacific Nucleic Acid Isolation and Purification Market, by Application
In 2024, the diagnostics application dominated the market in the Asia Pacific. This was because molecular testing volumes are growing across routine care. Hospitals and diagnostic chains are expanding PCR and syndromic panels for respiratory, gastrointestinal, and sexually transmitted infections. Each test starts with extraction, so NAIP demand rises directly in proportion to test throughput.
Asia Pacific Nucleic Acid Isolation and Purification Market, by Country
In 2024, China emerged as the leading player in the Asia Pacific nucleic acid isolation and purification market, primarily due to its extensive volume of molecular testing. The country boasts a wide network of hospitals and significant reference laboratory capacity, making DNA and RNA extraction a standard practice in routine diagnostics. Additionally, China's strong penetration of next-generation sequencing (NGS) in oncology and genetic testing further drives the demand for reliable, high-yield extraction from tissue and blood samples.
REGION
China to be the fastest-growing country in the Asia Pacific nucleic acid isolation and purification market during the forecast period
China leads the nucleic acid isolation and purification market in the Asia Pacific region due to its high volume of molecular testing. The country benefits from an extensive hospital network and significant reference laboratory capacity, which facilitates the use of DNA and RNA extraction in routine diagnostics. Additionally, China's strong penetration of next-generation sequencing (NGS) in oncology and genetic testing has driven demand for reliable, high-yield extraction methods from both tissue and blood samples.
ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION MATRIX
Thermo Fisher Scientific (Star) is a key player in the Asia Pacific nucleic acid isolation and purification market. This is because it has a strong presence across hospital labs, large diagnostic chains, reference laboratories, and biopharma research end users. The company's portfolio is well-suited to the high-throughput requirements of the Asia Pacific region and encompasses magnetic bead and column-based extraction kits, automation, ready-to-use workflows, as well as the necessary plastics and buffers. Takara Bio (Emerging Leader) is consolidating its position in the Asia Pacific region, leveraging its strong brand recognition in Japan and gradually expanding its influence to research and translational labs across the wider region.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific, Inc. (US)
- QIAGEN (Germany)
- F. Hoffman-La Roche (Switzerland)
- Danaher Corporation (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Takara Bio Inc. (Japan)
- KILPEST India Limited (India)
- Apical Scientific SDN. BHD (Malaysia)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 1.49 Billion |
| Market Forecast in 2030 (Value) | USD 2.65 Billion |
| Growth Rate | CAGR of 10.5% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Countries Covered | China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific |
WHAT IS IN IT FOR YOU: ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Asia Pacific diagnostics company planning to scale molecular testing |
|
|
RECENT DEVELOPMENTS
- September 2023 : QIAGEN launched two new nucleic acid extraction kits: the QIAwave RNeasy Plus Mini Kit and QIAwave DNA/RNA Mini Kit, eco-friendlier versions of the RNeasy Plus Mini Kit and the All DNA/RNA Mini Kit.
- January 2023 : QIAGEN launched the EZ2 Connect MDx platform for automated sample processing in diagnostic labs.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the Asia Pacific nucleic acid isolation and purification market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred for this research study include publications from government sources such as the World Health Organization (WHO), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), European Society of Human Genetics (ESHG), University Hospitals Southampton NHS Foundation Trust, Genomics England, Scottish Genome Partnership, Berlin Institute of Health, Max Delbrück Center for Molecular Medicine, and European Federation of Biotechnology (EFB). Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global market, which was then validated by primary research.
Primary Research
Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends and market dynamics.
Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side (hospitals and diagnostics centers, academic institutes and government organizations, pharmaceutical and biotechnology companies, and others) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, from Tier 1 and Tier 2 companies engaged in offering products) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. The primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The report presents a detailed assessment of the Asia Pacific nucleic acid isolation and purification market and qualitative inputs and insights from MarketsandMarkets. The total market size was determined after data triangulation from three different approaches. After completing each approach, the weighted average of the three approaches was taken based on each approach’s level of assumptions. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- From the list of manufacturers in the market, companies were identified and finalized from secondary research.
- Revenues for individual companies were gathered from public sources and databases.
- The business shares of leading players were gathered from secondary sources to the extent available. In certain cases, the shares of product businesses were ascertained through a detailed analysis of various parameters, including product portfolios and market positioning.
- Individual shares or revenue estimates were validated through expert interviews.
Approach: MnM Repository Analysis
For the estimation of the Asia Pacific nucleic acid isolation and purification market, related market reports in the MnM repository were considered. The global and regional market values of the Asia Pacific nucleic acid isolation and purification and dependent submarkets were extracted from the MnM repository and validated through secondary and primary research. The final global market size was triangulated through the average of all approaches and validated through primary interviews with industry experts.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition:
Asia Pacific nucleic acid isolation and purification is a set of molecular biology techniques used for the extraction of DNA and RNA for use in downstream applications, such as sequencing, cloning, and polymerase chain reaction. These downstream applications are important parts of life science research, molecular diagnostics, forensics, and genetic engineering.
Key Stakeholders
- Manufacturers and vendors of Asia Pacific nucleic acid isolation and purification kits and instruments
- Research associations related to genomics
- Hospitals & diagnostic centers
- Contract research organizations
- Healthcare institutions
- Research institutes
- Pharmaceutical & biotechnology companies
- Government & academic institutes
- Community centers
Report Objectives
- To define, describe, and forecast the Asia Pacific nucleic acid isolation and purification market by product, method, type, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations, in the global market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
- Further breakdown of the RoAPAC market, by country
Company Information
- Detailed analysis and profiling of additional market players (Up to five)
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Nucleic Acid Isolation and Purification Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Asia Pacific Nucleic Acid Isolation and Purification Market